CSL Limited Annual Report 2021/22 1 Our Purpose The people and science of CSL save lives. We develop and deliver innovative medicines that help people with serious and life-threatening conditions live full lives and protect the health of communities around the world. Our CSL Values guide us in creating sustainable value for our stakeholders. Arthur grew up playing sports and later moved on to weightlifting and bowling. In his late 30s, however, he was robbed of his mobility and left in severe pain by chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a rare neurological disorder that can lead to symptoms such as weakness, paralysis or impairment in motor function, especially in the arms and legs. After following a journey to diagnosis that lasted nearly 15 years, Arthur finally found the right treatment and is getting back to some of the activities that make himwho he is. He’s also advocating for fellow CIDP patients and encouraging others to do the same. As he puts it, ‘We need to speak up, work hard and be determined to overcome this.’ Staying active has always been a priority for Arthur. Arthur’s story
RkJQdWJsaXNoZXIy MjE2NDg3